ES2139674T3 - Metodo para tratar la sintomatologia del sindrome premenstrual con vitamina d o vitamina d y calcio. - Google Patents

Metodo para tratar la sintomatologia del sindrome premenstrual con vitamina d o vitamina d y calcio.

Info

Publication number
ES2139674T3
ES2139674T3 ES93921556T ES93921556T ES2139674T3 ES 2139674 T3 ES2139674 T3 ES 2139674T3 ES 93921556 T ES93921556 T ES 93921556T ES 93921556 T ES93921556 T ES 93921556T ES 2139674 T3 ES2139674 T3 ES 2139674T3
Authority
ES
Spain
Prior art keywords
vitamin
symptomatology
calcium
treat
premenstrual syndrome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93921556T
Other languages
English (en)
Inventor
Susan Thys-Jacobs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
THYS JACOBS SUSAN
Original Assignee
THYS JACOBS SUSAN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/945,319 external-priority patent/US5354743A/en
Application filed by THYS JACOBS SUSAN filed Critical THYS JACOBS SUSAN
Application granted granted Critical
Publication of ES2139674T3 publication Critical patent/ES2139674T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA PRESENTE INVENCION SE DIRIGE A UN METODO PARA TRATAR SINTOMAS ASOCIADOS CON SINDROME PREMENSTRUAL. EL METODO COMPRENDE ADMINISTRAR A UN INDIVIDUO EN NECESIDAD DE TRATAMIENTO UNA CANTIDAD DE VITAMINA D O UNA COMBINACION DE CALCIO ELEMENTAL Y VITAMINA D EFECTIVA PARA REDUCIR LOS SINTOMAS ASOCIADOS CON SINDROME PREMENSTRUAL.
ES93921556T 1992-09-15 1993-09-14 Metodo para tratar la sintomatologia del sindrome premenstrual con vitamina d o vitamina d y calcio. Expired - Lifetime ES2139674T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/945,319 US5354743A (en) 1992-09-15 1992-09-15 Method for the treatment of premenstrual syndrome with vitamin D
US08/059,682 US6228849B1 (en) 1992-09-15 1993-05-10 Method for treating symptoms associated with premenstrual syndrome by administering a combination of calcium and vitamin D

Publications (1)

Publication Number Publication Date
ES2139674T3 true ES2139674T3 (es) 2000-02-16

Family

ID=26739051

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93921556T Expired - Lifetime ES2139674T3 (es) 1992-09-15 1993-09-14 Metodo para tratar la sintomatologia del sindrome premenstrual con vitamina d o vitamina d y calcio.

Country Status (8)

Country Link
US (1) US5443850A (es)
EP (1) EP0660718B1 (es)
JP (1) JP3676805B2 (es)
AT (1) ATE187332T1 (es)
CA (1) CA2144728C (es)
DE (1) DE69327248T2 (es)
ES (1) ES2139674T3 (es)
WO (1) WO1994006435A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716454B2 (en) * 1994-09-23 2004-04-06 Laboratorie Innothera, Société Anonyme Therapeutic combination of vitamin and calcium in unitary galenic tablet form, a method of obtaining it, and the use thereof
US5770215A (en) * 1997-01-06 1998-06-23 Moshyedi; Emil Payman Multivitamin/vascular occlusion inhibiting composition
DE19844836A1 (de) * 1998-09-30 2000-04-20 Hexal Ag Pharmazeutisch, wirksames, pflanzliches Präparat zur Behandlung von Migräne
AU772384B2 (en) * 2001-05-09 2004-04-29 Nestec S.A. Vitex agnus castus extract
US7198653B2 (en) 2003-07-31 2007-04-03 Delavau Llc Calcium carbonate granulation
JP5303276B2 (ja) * 2005-10-12 2013-10-02 プロヴェンティヴ セラピュティックス リミテッド ライアビリティ カンパニー ２５−ヒドロキシビタミンｄ不足および欠乏を治療するための方法および製品
US20070098819A1 (en) * 2005-11-02 2007-05-03 Susan Thys-Jacobs Micronutrient supplement with calcium, vitamin D or calcium & vitamin D combination for premenstrual syndrome, postpartum depression, depression and panic attacks
US9138414B1 (en) 2006-09-15 2015-09-22 Delavau Llc Calcium supplement having enhanced absorption
BRPI0907950A2 (pt) * 2008-02-13 2015-08-04 Dsm Ip Assets Bv Tratamento de hiperglicemia com 25-hidroxivitamina d3
EP2321273B1 (en) * 2008-07-24 2014-11-19 Wisconsin Alumni Research Foundation Once-a-week administration of 25-hydroxy vitamin d3 to sustain elevated steady-state pharmacokinetic blood concentration
WO2011085293A1 (en) * 2010-01-08 2011-07-14 Beth Israel Deaconess Medical Center Methods and compositions for the treatment of migraine headaches
US10932711B2 (en) 2017-02-27 2021-03-02 Payman Sadeghi Method and system for neurohydrodissection
US10456419B2 (en) 2017-02-27 2019-10-29 Payman Sadeghi Method for treating migraine headaches

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4225596A (en) * 1978-10-13 1980-09-30 Wisconsin Alumni Research Foundation Method for treating calcium imbalance and improving calcium absorption in mammals
JPS59120078A (ja) * 1982-12-28 1984-07-11 Norio Someya 健康増進剤
US4501738A (en) * 1983-06-30 1985-02-26 Kureha Kagaku Kogyo Kabushiki Kaisha Pharmaceutical composition containing 24,25-dihydroxycholecalciferol as an active ingredient to treat pain, pyrexia or inflammatory diseases
US4806354A (en) * 1984-04-06 1989-02-21 Green James P Health food composition
CA1250525A (en) * 1985-01-03 1989-02-28 Larry Barron Composition for the relief of menstrual symptoms
US4812303A (en) * 1986-04-03 1989-03-14 Copley Pharmaceuticals, Inc. High dose calcium tablet
US4946679A (en) * 1988-07-25 1990-08-07 Thys Jacobs Susan Method for the treatment of premenstrual syndrome
GB2254556B (en) * 1991-04-11 1995-04-12 Fisons Plc Formulations containing linolenic acid

Also Published As

Publication number Publication date
JPH08505122A (ja) 1996-06-04
US5443850A (en) 1995-08-22
ATE187332T1 (de) 1999-12-15
DE69327248T2 (de) 2000-07-06
JP3676805B2 (ja) 2005-07-27
WO1994006435A1 (en) 1994-03-31
EP0660718A4 (en) 1997-05-21
DE69327248D1 (de) 2000-01-13
EP0660718A1 (en) 1995-07-05
CA2144728C (en) 2005-04-26
EP0660718B1 (en) 1999-12-08
CA2144728A1 (en) 1994-03-31

Similar Documents

Publication Publication Date Title
ES2139674T3 (es) Metodo para tratar la sintomatologia del sindrome premenstrual con vitamina d o vitamina d y calcio.
DE69526340D1 (de) Botulinumtoxin ZUR REDUKTION VON Migraine -KOPFSCHMERZEN
ES2120948T3 (es) Procedimiento y composiciones que mejoran los sintomas de la sepsis.
PT971713E (pt) Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao
NO952469D0 (no) Terapautisk kombinasjon som inneholder interferon
PT871473E (pt) Utilizacao de il-10 para curar feridas com cicatrizacao reduzida
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
DE69230046D1 (de) 2-Bromomelatonin zur Behandlung von Schlafstörungen
ES2153384T3 (es) Metodo para tratar la esclerosis multiple.
BG99261A (en) Steroid glycosides for the treatment of hyperchlesterolemia
PT705100E (pt) Guanidinas substituidas terapeuticas
ES2074565T3 (es) Empleo de melatonina para tratar el sindrome pre-menstrual.
ZA936799B (en) Method for treating symptoms associated with premenstrual syndrome by administering vitamin D or A combination of calcium and vitamin D
DK71387A (da) Terapeutisk middel til behandling af psoriasis
SE9601396D0 (sv) New therapeutic treatment 2
MD1521F2 (en) Methods of thrombus forming inhibition, methods of treatment of thrombotic states, pharmaceutical compositions and kit for treatment of thrombotic states
ES2195655T3 (es) Procedimiento para tratar fiebre hemorragica virica con proteina c.
NO993627L (no) Anvendelse av en forbindelse for fremstilling av et legemiddel
ES2058771T3 (es) Preparado combinado con efecto antitrombotico.
ES2026485T3 (es) Esteres de salsalato con guayacol para tratar bronconeumopatias flogisticas.
ATE435023T1 (de) Therapeutische formulierungen, die schlangen- und/oder insektengift enthalten, zur prophylaxe und therapie von neoplasmen
ATE149840T1 (de) Behandlung von leberkrebs
ES8602569A1 (es) Procedimiento de obtencion de una fraccion de hidrocarburos a partir de cera de abeja.
NO962221D0 (no) Anvendelse av dimeticon for behandling av konstipasjon
MX9304878A (es) Uso de un azaspirano substituido en la fabricacion de un medicamento para utilizarse en el tratamiento de psoriasis.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 660718

Country of ref document: ES